(4-((3,5-Dimethoxybenzyl)oxy)-3,5-dimethylphenyl)boronic acid

Catalog No. :
ACBZOT623
CAS No. :
1072951-94-0
Molecular Formula :
C17H21BO5
Molecular Weight :
316.16

IUPAC Name:(4-((3,5-dimethoxybenzyl)oxy)-3,5-dimethylphenyl)boronic acid

(4-((3,5-Dimethoxybenzyl)oxy)-3,5-dimethylphenyl)boronic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg96%$77.00Login to see priceInquiryInquiry
1g96%$211.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(4-((3,5-Dimethoxybenzyl)oxy)-3,5-dimethylphenyl)boronic acid
IUPAC Name(4-((3,5-dimethoxybenzyl)oxy)-3,5-dimethylphenyl)boronic acid
MDL No.MFCD08276774
Molecular FormulaC17H21BO5
Molecular Weight316.16
SMILESCC1=C(OCC2=CC(OC)=CC(OC)=C2)C(C)=CC(B(O)O)=C1
InChI KeyVZHFHGUMGVBYBU-UHFFFAOYSA-N
Synonym1072951-94-0 | (4-((3,5-Dimethoxybenzyl)oxy)-3,5-dimethylphenyl)boronic acid | 3,5-Dimethyl-4-(3',5'-dimethoxybenzyloxy)phenylboronic acid | [4-[(3,5-dimethoxyphenyl)methoxy]-3,5-dimethylphenyl]boronic acid | {4-[(3,5-Dimethoxyphenyl)methoxy]-3,5-dimethylphenyl}b
CAS No.1072951-94-0
PubChem CID56844280

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACBZOT623 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBZOT623 route product structure diagram
    ACBZOT6231072951-94-0
Inquiry

2. ACBZOT623 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBZOT623 route product structure diagram
    ACBZOT6231072951-94-0
Inquiry

Comments (0)